Incyte | INCY - Ebit

株価
94.65
毎日の変更
-0.82 -0.86%
毎月
2.62%
毎年
59.99%
Q2 予測
92.62




Ebit 変化する 日付
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12